[11C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain
Author Information
Author(s): Hashimoto Kenji, Nishiyama Shingo, Ohba Hiroyuki, Matsuo Masaaki, Kobashi Tatsuhiko, Takahagi Makoto, Iyo Masaomi, Kitashoji Takeru, Tsukada Hideo
Primary Institution: Chiba University Center for Forensic Mental Health, Chiba, Japan
Hypothesis
Can [11C]CHIBA-1001 be used as a PET ligand for imaging α7 nAChRs in the non-human primate brain?
Conclusion
[11C]CHIBA-1001 could be a novel useful PET ligand for studying α7 nAChRs in the brain of patients with neuropsychiatric diseases.
Supporting Evidence
- CHIBA-1001 was found to be a highly selective ligand at α7 nAChRs.
- The distribution of radioactivity in the monkey brain after administration of [11C]CHIBA-1001 was consistent with the regional distribution of α7 nAChRs.
- The binding of [11C]CHIBA-1001 in the frontal cortex was significantly decreased by subchronic administration of PCP.
Takeaway
[11C]CHIBA-1001 is a special dye that helps doctors see important parts of the brain that are affected in diseases like schizophrenia.
Methodology
The study involved receptor binding assays and PET imaging in conscious monkeys to evaluate the distribution of [11C]CHIBA-1001.
Limitations
The small sample size of monkeys (n=3) may limit the generalizability of the findings.
Participant Demographics
Eleven young-adult male rhesus monkeys (Macaca mulatta) weighing from 4 to 6 kg.
Statistical Information
P-Value
0.011
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website